Performance Culture Over Portfolio Growth: How Chemical CEOs Are Redefining "Success" for a Near-Zero-Growth Decade
Performance Culture Over Portfolio Growth: How Chemical CEOs Are Redefining "Success" for a Near-Zero-Growth Decade
The chemical industry has entered a phase that consultants and trade groups increasingly describe as the bottom of the capital cycle. Global production growth forecasts that once sat near 3.5% have been revised downward, in some outlooks toward or below 2% for 2025–2026. Overcapacity in key chains, soft demand in housing, automotive and durables, elevated energy and regulatory costs in Europe, and persistent geopolitical uncertainty have combined to make volume-led expansion a less reliable path to value. In response, chemical CEOs are quietly rewriting the definition of success: from portfolio growth and capacity additions toward structural cost reduction, margin recovery, cash preservation and a tighter performance culture.
Oliver Wyman’s 2026 outlook and Deloitte’s 2026 Chemical Industry Outlook both capture the shift. The old playbook—build capacity, chase share, ride the cycle—has given way to a new one centred on profitability, resilience and selective transformation. Winning now looks less like the largest top line and more like the most credible earnings and cash trajectory in a low-growth environment.
From Growth Assumptions to Margin Reality
For much of the past decade, strategy presentations emphasised end-market growth, geographic expansion and new capacity. Those assumptions have been repeatedly cut. When industry-wide volume growth settles in the low single digits—or turns negative in some regions and chains—incremental tonnes no longer guarantee incremental profit. Overcapacity keeps operating rates under pressure; price and margin become the binding constraints.
CEOs have responded by elevating cost and performance metrics in internal targets and external guidance. Fixed-cost reduction, working-capital discipline, plant utilisation improvement and portfolio pruning now feature as prominently as, or more prominently than, volume growth. The companies that can expand margins and free cash flow on a flat or only modestly rising sales base are the ones that will fund dividends, selective growth projects and the next wave of decarbonisation.
The New Performance Levers
Several operational and financial levers define the current playbook.
Structural cost reduction has moved from periodic programme to continuous discipline. Energy efficiency, procurement, logistics, overhead and site fixed costs are under sustained scrutiny. In higher-cost regions, especially Europe, the alternative to deep cost action is further capacity rationalisation or exit.
Portfolio simplification is accelerating. Non-core or subscale businesses are being prepared for sale or closure so that capital and management attention concentrate on positions with clearer feedstock, technology or end-market advantage. Carve-outs and divestments are no longer only about raising cash; they are about raising the average quality and resilience of what remains.
Capital allocation has become more selective. Growth capital is directed toward specialties, advantaged feedstocks, circular or low-carbon projects and digital/AI-enabled productivity rather than broad-based commodity expansion. Maintenance and turnaround spending is prioritised to protect reliability and avoid value-destroying outages.
Performance culture is being reinforced through clearer accountability, tighter KPIs and, in many cases, compensation metrics that emphasise margin, cash and safety alongside or instead of pure volume. The message from the top is that “winning” in this decade is measured by returns and resilience, not by the size of the asset base.
Regional and Segment Differences
The pressure is not uniform. Specialty chemicals and segments linked to agriculture, semiconductors, clean technology and certain consumer applications retain better growth and pricing prospects. Commodity chains tied to construction and traditional durables face the heaviest overcapacity and margin compression. European producers confront structural energy and regulatory cost disadvantages that make cost discipline and portfolio choices even more urgent. US producers with feedstock advantage have relatively more room, yet they too are prioritising through-cycle earnings over peak-volume ambitions. Asian capacity additions continue to shape global balances, reinforcing the need for Western producers to compete on cost, differentiation and customer intimacy rather than scale alone.
What Boards and Investors Now Reward
Boards and institutional investors have adjusted their scorecards accordingly. Guidance that emphasises volume growth without a clear margin and cash bridge is met with scepticism. Guidance that pairs modest volume assumptions with explicit cost, working-capital and portfolio actions is more likely to be judged credible. ESG and decarbonisation commitments remain on the agenda, but they are increasingly expected to be delivered within a tighter capital and cost envelope rather than as add-ons to an expanding asset base.
The CEOs who succeed in this environment will be those who can institutionalise cost and performance discipline without destroying the organisational capacity to innovate and to capture the next upturn when it arrives. That balance—rigour without rigidity—is the cultural test of the near-zero-growth decade.
Outlook
Global chemicals production growth has been revised down into a range that no longer supports the old capacity-expansion definition of success. Oliver Wyman, Deloitte and industry associations describe a sector at or near the bottom of the capital cycle, with overcapacity, soft demand and cost pressure as the dominant facts. In that setting, chemical CEOs are redefining winning as margin recovery, cash generation, portfolio quality and operational performance. The companies that embed that definition in targets, incentives and capital allocation will be better positioned to navigate a low-growth stretch and to invest selectively when conditions improve. Those that continue to measure success primarily by volume and gross capacity will find the next several years unforgiving.
Sources
Acrylonitrile Butadiene Styrene (ABS)
Found this useful?
